Demographic Characteristics of Patients Who Utilize Biologics for Severe Asthma: A Real-World European Perspective

被引:0
|
作者
Valliant, S. [1 ]
Zhang, S. [1 ]
Harvey, J. [1 ]
Mu, G. [1 ]
Jakes, R. [2 ]
Emeanuru, K. [3 ]
Palhares, K. Bruini Pitta [3 ]
Andre, M. [3 ]
Cristancho, R. Alfonso [1 ]
机构
[1] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[2] GSK, Resp R&D Value Evidence & Outcomes VEO, Brentford, England
[3] Evidera, PPD, Houston, TX USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4754
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
    Kanniess, Frank
    Tamasi, Lilla
    Mroz, Robert R.
    Bakakos, Petros
    Tubis, Susanne
    Plat, Gustavo Resler
    Shavit, Anat
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR
    Park, So -Young
    Lee, Sun-Kyung
    Song, Woo -Jung
    Kim, Min-Hye
    Ban, Ga-Young
    Kim, Joo-Hee
    Kim, Byung-Keun
    Kwon, Jae -Woo
    Sohn, Kyoung-Hee
    Lee, Hwa Young
    Jung, Jae -Woo
    Park, Chan -Sun
    Kang, Sung-Yoon
    Yang, Min Suk
    Lee, Jae Hyun
    Jang, An -Soo
    Kim, So Ri
    Lee, Taehoon
    Rhee, Chin Kook
    Park, Heung-Woo
    Kim, Sang-Hoon
    Chang, Yoon-Seok
    Koh, Young-Il
    Lee, Byung-Jae
    Park, Hae-Sim
    Kim, Sang-Heon
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (03) : 253 - 266
  • [3] Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics
    Townend, John
    Tran, Trung N.
    Martin, Neil
    Menzies-Gow, Andrew N.
    Wang, Eileen
    Wechsler, Michael E.
    Canonica, Giorgio Walter
    Heffler, Enrico
    Perez-De-Llano, Luis
    Cosio, Borja G.
    Hew, Mark
    Peters, Matthew
    Gibson, Peter G.
    Bosnic-Anticevich, Sinthia
    Heaney, Liam G.
    Jackson, David J.
    Pfeffer, Paul E.
    Busby, John
    Salvi, Sundeep
    Christoff, George C.
    Popov, Todor A.
    Porsbjerg, Celeste M.
    Torres-Duque, Carlos A.
    Al-Lehebi, Riyad
    Al-Ahmad, Mona
    Perng, Diahn-Warng
    Bergeron, Celine
    Sadatsafavi, Mohsen
    Mahboub, Bassam
    Iwanaga, Takashi
    Maspero, Jorge
    Kuna, Piotr
    Chin, Kook Rhee
    Larenas-Linnemann, Desiree
    Papadopoulos, Nikolaos G.
    Papaioannou, Andriana I.
    Fonseca, Joao A.
    Koh, Mariko Siyue
    Costello, Richard W.
    Price, David
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Characteristics of severe asthma patients on biologics: a real-life European registry study
    Principe, Stefania
    Richards, Levi B.
    Hashimoto, Simone
    Kroes, Johannes Anthon
    Van Bragt, Job J. M. H.
    Vijverberg, Susanne J.
    Sont, Jacob K.
    Scichilone, Nicola
    Bieksiene, Kristina
    Ten Brinke, Anneke
    Csoma, Zsuzsanna
    Dahlen, Barbro
    Gemicioglu, Bilun
    Grisle, Ineta
    Kuna, Piotr
    Lazic, Zorica
    Mihaltan, Florin
    Popovic-Grle, Sanja
    Skrgat, Sabina
    Marcon, Alessandro
    Caminati, Marco
    Djukanovic, Ratko
    Porsbjerg, Celeste
    Van der Zee, Anke-Hilse Maitland
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [5] Biologics in severe asthma: the role of real-world evidence from registries
    Paoletti, Giovanni
    Pepys, Jack
    Casini, Marta
    Di Bona, Danilo
    Heffler, Enrico
    Goh, Celine Y. Y.
    Price, David B.
    Canonica, Giorgio Walter
    EUROPEAN RESPIRATORY REVIEW, 2022, 31 (164):
  • [6] Real-world biomarker variability and effects of biologics on severe asthma in Alberta
    Ramsahai, J. Michael
    Randhawa, Arsh
    Foster, Andrew
    Geyer, Lee
    McMullen, Suzanne
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2024,
  • [7] Assessment of Real-World Escalation to Biologics in US Patients With Asthma
    Bender, Bruce
    Oppenheimer, John
    George, Maureen
    Brown, Randall
    Patel, Ayush
    Hill, Tanisha
    Boe, Amanda
    Herrera, Ernesto Mayen
    Dotiwala, Zenobia
    Casciano, Julian
    Bernstein, Jonathan A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11): : 2941 - 2948
  • [8] Real-World Response To Anti-Eosinophil Biologics For Severe Eosinophilic Asthma
    Surjancev, Ivana
    Viswanathan, Ravi
    Denlinger, Loren
    Mathur, Sameer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB18 - AB18
  • [9] Demographics and Characteristics of Patients Who Initiate Biologics for Severe Asthma in Japan
    Harvey, J.
    Zhang, S.
    Mu, G.
    Valliant, S.
    Cristancho, R. Alfonso
    Ishii, T.
    Suzuki, T.
    Kunishige, H.
    Jakes, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] REAL-WORLD BIOLOGICS USE IN EUROPEAN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): CHARACTERISTICS AND OUTCOMES
    Hwee, J.
    Huynh, L.
    Baylis, L.
    Alfonso-Cristancho, R.
    Khanal, A.
    da Costa, W.
    Duh, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S12 - S13